{"nct_id":"NCT00621361","title":"Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients","status":"COMPLETED","status_verified_date":"2012-12","start_date":"2008-02","start_date_type":null,"primary_completion_date":"2009-08","primary_completion_date_type":"ACTUAL","completion_date":"2012-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}